Long-term effect of carbapenem preauthorization: an interrupted time-series study over 20 years
Journal of Hospital Infection · 2025
DOI: 10.1016/j.jhin.2025.06.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hospital Infection, 2025. Verfasst von T Urakami und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Disease and Hospital Epidemiology, Saga University Hospital, Saga, Japan. Hauptthemen laut MEDLINE: Carbapenems, Anti-Bacterial Agents, Cross Infection, Drug Utilization. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kurume University.
Abstract (Originalsprache)
BACKGROUND: Preauthorization of carbapenems is considered effective in reducing carbapenem overuse; however, long-term evaluations are lacking. AIM: We aimed to evaluate the long-term effects of judicious carbapenem restriction over almost two decades in a tertiary teaching hospital in Japan. METHODS: Interrupted time-series (ITS) analysis was applied to investigate changes in the level and trend of antimicrobial use density (AUD) of carbapenems by comparing the pre-intervention (2004 and 2005) and intervention (2006-2023) periods. Furthermore, this study explored the relationship between carbapenem AUD in hospitalized patients, the mortality rate of hospital-acquired bacteraemia, and the prevalence of bacteraemia caused by antibiotic-resistant nosocomial pathogens. FINDINGS: The ITS analysis demonstrated remarkably significant reductions in the level change of carbapenem AUD following the preauthorization (-0.367 per 100 patient days (95% confidence interval (CI), -0.131 to -0.603; P=0.002). In addition, the trend shift was -0.014 per 100 patient days (95% CI, -0.001 to -0.028; P=0.048). Following the implementation of carbapenem preauthorization, no increase in the 28-day mortality due to nosocomial bacteraemia was observed. Significant positive correlations were found between carbapenem AUD and the prevalence of meticillin-resistant Staphylococcus aureus (correlation coefficient (ρ) = 0.77 (P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Disease and Hospital Epidemiology, Saga University Hospital, Saga, Japan.
- Division of Infectious Disease and Hospital Epidemiology, Saga University Hospital, Saga, Japan; Department of Internal Medicine, Nayutanomori Hospital, Saga, Japan. Electronic address: aokiy3@cc.saga-u.ac.jp.
Förderung
- Kurume University
Zitieren
APA
Urakami, T., Matono, T., Oka, Y., & Aoki, Y. (2025). Long-term effect of carbapenem preauthorization: an interrupted time-series study over 20 years. Journal of Hospital Infection. https://doi.org/10.1016/j.jhin.2025.06.005
Vancouver
Urakami T, Matono T, Oka Y, Aoki Y. Long-term effect of carbapenem preauthorization: an interrupted time-series study over 20 years. Journal of Hospital Infection. 2025. doi:10.1016/j.jhin.2025.06.005
BibTeX
@article{Urakami2025,
author = {Urakami, T and Matono, T and Oka, Y and Aoki, Y},
title = {Long-term effect of carbapenem preauthorization: an interrupted time-series study over 20 years},
journal = {Journal of Hospital Infection},
year = {2025},
doi = {10.1016/j.jhin.2025.06.005}
}
EUVIMED